(Q58071292)

1

0 references

Tina Fuchs

2

0 references

Giridhar Mudduluru

4

0 references

Gabriele Maurer

5

0 references

Stefan Post

6

0 references

Yi Tang

7

0 references

Marian T. Nakada

8

0 references

Li Yan

9

0 references

Heike Allgayer

Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect.

10

0 references

language of work or name

English

0 references

publication date

15 October 2009

0 references

published in

Cancer

0 references

volume

115

0 references

issue

20

0 references

page(s)

4667-4678

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

Immunocytochemical phenotyping of disseminated tumor cells in bone marrow by uPA receptor and CK18: investigation of sensitivity and specificity of an immunogold/alkaline phosphatase double staining protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

Tumorigenic potential of extracellular matrix metalloproteinase inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Cancer. Proteases--invasion and more

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

The Relationship Between Micrometastases in the Bone Marrow, Histopathologic Features of the Primary Tumor in Breast Cancer and Prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Prognostic significance of bone marrow micrometastases in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Detection of micrometastatic disease in bone marrow: is it ready for prime time?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Combined transcriptome and genome analysis of single micrometastatic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Expression of the extracellular matrix metalloproteinase inducer (EMMPRIN) and the matrix metalloproteinase-2 in bronchopulmonary and breast lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021

Bone marrow metastases: a survey of nonhematologic metastases with immunohistochemical study of metastatic carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24516

7 January 2021